CHIARAMONTE, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.582
EU - Europa 240
AS - Asia 140
OC - Oceania 1
Totale 2.963
Nazione #
US - Stati Uniti d'America 2.580
CN - Cina 127
FI - Finlandia 66
SE - Svezia 63
DE - Germania 33
IT - Italia 28
GB - Regno Unito 22
UA - Ucraina 21
VN - Vietnam 11
IE - Irlanda 5
CA - Canada 2
IN - India 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 2.963
Città #
Fairfield 354
Houston 305
Woodbridge 281
Chandler 256
Ann Arbor 190
Wilmington 168
Ashburn 166
Cambridge 150
Seattle 150
Jacksonville 96
Princeton 61
Beijing 57
San Diego 41
Medford 38
Des Moines 32
Nanjing 32
Helsinki 19
Boardman 15
Roxbury 14
Dong Ket 11
Falls Church 11
Norwalk 10
Nanchang 9
Jiaxing 6
London 6
New York 6
Shenyang 6
Changsha 5
Dublin 5
Hebei 5
Ogden 5
Kharkiv 4
Salerno 4
Borås 3
Indiana 3
Paluello 3
Redwood City 3
San Francisco 3
Chiswick 2
Edgware 2
Kilburn 2
Munich 2
Musile di Piave 2
Padova 2
Tianjin 2
Toronto 2
Acton 1
Atlanta 1
Auckland 1
Boston 1
Falkenstein 1
Guangzhou 1
Haikou 1
Islington 1
Jinan 1
Lappeenranta 1
Los Angeles 1
Mestre 1
New Bedfont 1
Pignone 1
Rockville 1
Simi Valley 1
Taiyuan 1
Taizhou 1
Tokyo 1
Urbana 1
Venezia 1
Venice 1
Winston-Salem 1
Totale 2.572
Nome #
Hepatitis A and hepatitis B virus infection in children and adolescents in north-east Italy. 112
Hepatitis C virus infection in pregnancy. 107
Acute hepatitis in elderly patients. 107
Colchicine in chronic hepatitis B: a pilot study 104
Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. 101
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver 100
Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged. 93
Prevalence of familial disease in primary biliary cirrhosis in Italy 92
Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine 91
Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). 91
Are homes for the elderly still a risk area for HBV infection? 90
HEPATOCELLULAR PROLIFERATION, TNF-ALPHA AND INFLAMMATION IN PRIMARY BILIARY-CIRRHOSIS (PBC) 86
THE EARLY DIAGNOSIS IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS: A 35-YEAR FOLLOW-UP IN A SINGLE CENTRE 85
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. 82
The early diagnosis improves survival in primary biliary cirrhosis: A 35-year follow-up in a single centre 78
Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring 73
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. 73
Two new serum immunoassays (RIA and EIA) for the determination of M2 antimitochondrial antibodies in primary biliary cirrhosis. 72
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. 72
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial 68
Double-blind, controlled study of tauroursodeoxycholic acid in elderly patients with hepatitis C virus-related cirrhosis. 66
Oxidative damage in chronic and acute liver disease 65
Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. 64
The Italian munticentre randomized controlled trial of ursodeoxycholic acid plus colchicine in symptomatic primary biliary cirrhosis 63
Seroprevalence of hepatitis B and C in an institution for mentally retarded 62
Hepatitis B virus infection and cyclophosphamide. 61
Hepatitis B virus (HBV) in the elderly: an underestimated problem? 60
Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects. 59
Viral hepatitis B. Seroepidemiological study in Veneto 58
Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. 58
Hepatitis B virus serum markers (HBsAg, antiHBs, antiHBc): prevalence among drug addicts in north-east Italy. 51
TUMOR-NECROSIS-FACTOR-ALPHA BEHAVIOR IN SERUM DURING RECOMBINANT-ALPHA-2B-INTERFERON TREATMENT OF CHRONIC VIRAL-HEPATITIS 49
Emocromatosi genetica 47
Biochemical markers of hepatic fibrosis in primary biliary cirrhosis 47
Prediction of Iron Overload With A New Mass Spectrometry Method For Detection of Hepcidin In Plasma 46
Hormone metabolism and liver disease: implications in adrenal, bone and gonadal pathophysiology 45
Antigliadin antibody classes in chronic liver disease. 43
Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients 43
Hyperthyroidism associated with primary cirrhosis. Two case reports 38
Esami di laboratorio in presenza di alterazioni dell'apparato gastroenterico 37
Fisiopatologia epatica 31
Risposta ad un'extra-dose di vaccino contro l'HBV e durata di anti-HBs in non-responders al primo ciclo vaccinale. 30
Malattie del fegato e delle vie biliari 29
Fisiopatologia epatica 14
Le prove di laboratorio 11
Malattia di Wilson 10
Totale 2.964
Categoria #
all - tutte 10.872
article - articoli 9.400
book - libri 141
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 973
Totale 21.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019232 0 0 0 0 0 0 0 0 0 0 125 107
2019/2020583 109 17 6 33 66 48 54 62 62 56 43 27
2020/2021278 13 19 15 40 7 19 12 28 46 24 31 24
2021/2022539 7 57 70 22 35 55 33 58 25 15 43 119
2022/2023488 98 55 10 62 79 82 0 34 45 1 21 1
2023/2024138 12 29 39 15 4 8 4 19 7 1 0 0
Totale 2.964